Structural basis for telmisartan-mediated partial activation of PPAR gamma

Hypertens Res. 2012 Jul;35(7):715-9. doi: 10.1038/hr.2012.17. Epub 2012 Feb 23.

Abstract

Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how telmisartan partially activates PPARγ, we determined the ternary complex structure of PPARγ, telmisartan, and a coactivator peptide from steroid receptor coactivator-1 at a resolution of 2.18 Å. Crystallographic analysis revealed that telmisartan exhibits an unexpected binding mode in which the central benzimidazole ring is engaged in a non-canonical--and suboptimal--hydrogen-bonding network around helix 12 (H12). This network differs greatly from that observed when full-agonists bind with PPARγ and prompt high-coactivator recruitment through H12 stabilized by multiple hydrogen bonds. Binding with telmisartan results in a less stable H12 that in turn leads to attenuated coactivator binding, thus explaining the mechanism of partial activation.

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / chemistry*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Benzimidazoles / chemistry*
  • Benzimidazoles / pharmacology
  • Benzoates / chemistry*
  • Benzoates / pharmacology
  • Humans
  • Hydrogen Bonding
  • Nuclear Receptor Coactivator 1 / chemistry
  • PPAR gamma / agonists*
  • Structure-Activity Relationship
  • Telmisartan

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Benzoates
  • PPAR gamma
  • Nuclear Receptor Coactivator 1
  • Telmisartan